Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, and Jiangsu Key Laboratory for High Technology Research of TCM Formulae, and National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China; School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China.
Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, and Jiangsu Key Laboratory for High Technology Research of TCM Formulae, and National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, China.
J Pharm Biomed Anal. 2024 Jun 15;243:116111. doi: 10.1016/j.jpba.2024.116111. Epub 2024 Mar 15.
Xijiao Dihuang decoction (XDT), a famous formula, was usually used to improve the prognosis of patients with blood-heat and blood-stasis syndrome-related diseases. There were some mutual promotion and mutual assistance herb pairs in XDT. However, the exact functions of these herb pairs in the compatibility of XDT were not elucidated due to the lack of appropriate methodologies. Based on the theory of serum pharmacochemistry, a systematic method was established for the qualitative and quantitative analysis of characteristic components in the extracts and drug-containing plasma samples of XDT and its relational mutual promotion/assistance herb pairs. For qualitative analysis, 85 characteristic components were identified using the liquid chromatography with triple time-of-flight mass/mass spectrometry (LC-Triple QTOF-MS/MS) based on the mass defect filtering, product ion filtering, neutral loss filtering and isotope pattern filtering techniques. For quantitative detection, a relative quantitation assay using an extract ion chromatogram (EIC) of the full scan MS experiment was validated and employed to assess the quantity of the 85 identified compounds in the test samples of single herb, herb pairs and XDT. The results of multivariate statistical analyses indicated that both the assistant and guide herbs could improve the solubilization of active compounds from the sovereign and minister herbs in XDT in vitro, might change the trans-membrane transportation, and regulate metabolism in vivo. The methods used in present study might be also valuable for the investigation of multiple components from other classic TCM formulas for the purpose of compatibility feature study.
犀角地黄汤(XDT)是一种著名的方剂,通常用于改善血热血瘀证相关疾病患者的预后。XDT 中有一些相互促进和相互协助的药对。然而,由于缺乏适当的方法,这些药对在 XDT 配伍中的确切作用尚不清楚。基于血清药物化学理论,建立了犀角地黄汤及其相关药对提取液和含药血浆样品中特征成分的定性和定量分析的系统方法。定性分析中,采用基于质量亏损过滤、产物离子过滤、中性丢失过滤和同位素模式过滤技术的三重四级杆飞行时间质谱/质谱联用(LC-Triple QTOF-MS/MS),鉴定了 85 种特征成分。定量检测中,采用全扫描 MS 实验的提取离子色谱(EIC)进行相对定量分析,并用于评估单味药、药对和 XDT 测试样品中 85 种鉴定化合物的含量。多变量统计分析的结果表明,辅助和引导药在体外都能提高 XDT 中君臣药有效成分的溶解度,可能改变跨膜转运,并在体内调节代谢。本研究中使用的方法对于研究其他经典中药方剂的多种成分,也可能对配伍特征研究具有重要价值。